 | CRISPR Therapeutics AG | |||
| NGM : CRSP || Location: Switzerland | ||||
$53.91+0.18 (+0.34%) |
1.35 M | 52.81 - 54.94 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 14.745 M |
| March 28, 2024 | 14.757 M |
| March 15, 2024 | 14.724 M |
| Feb. 29, 2024 | 15.062 M |
| Feb. 15, 2024 | 14.875 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.07 | 1.10 | 1592.54% |
| 09/30/2023 | -1.99 | -1.41 | 29.14% |
| 06/30/2023 | -2.16 | -0.98 | 54.63% |
| 03/31/2023 | -1.74 | -0.67 | 61.43% |
| 12/31/2022 | -2.35 | -1.41 | 39.87% |
CRSP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 84.883M | Shares Float | 78.845M |
| Short Float | 14.745M | Market Cap | 4560.76M |
| Institution ownership | 69.16% | Insider ownership | 1.858% |
| Earnings Date | 04/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.94 | Forward EPS | -4.23 |